CELINA NAVARRO: Open Payments
NPI 1134755226 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 59 payments from 18 companies in 2025. Trend: 2023 $1,564 · 2024 $1,035 · 2025 $1,305
Food & beverage: $1,277Education: $28
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $288 |
| Alexion Pharmaceuticals, Inc. | 5 | $143 |
| UCB, Inc. | 6 | $134 |
| ARGENX US, INC. | 6 | $119 |
| Tanabe Pharma America, Inc. | 3 | $82 |
| Biogen, Inc. | 3 | $63 |
| Medtronic, Inc. | 1 | $56 |
| Janssen Biotech, Inc. | 2 | $55 |
| SK Life Science, Inc. | 2 | $54 |
| Neurelis, Inc. | 2 | $53 |
Products named: UBRELVY, ULTOMIRIS, VYVGART HYTRULO, BOTOX, Briviact, VUMERITY, QULIPTA, PERCEPT PC BRAINSENSE.
Industry payments across TX — which companies pay providers there.
